Property:Outcome timeline
This is a property of type Text.
D
T0: Baseline
T1: after at least 6 weeks +
E
Ehrenpreis et al. (2005): A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy +
T0: Baseline
T1: 30 Tage
T2: 60 tage
T3: 90 Tage +
Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy +
T0: Baseline
T1:
* Diarrhea and vomiting scaling weekly for 4 weeks (2nd-5th)
* daily diary (number, consistency of stools, occurrence of symptoms such as nausea, vomiting and gastrointestinal cramps) from day 1 of the 2nd week to the end of the 5th week +
Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study +
T0: before radiotherapy
Once a week during treatment
After treatment
6 weeks after treatment +
F
Fahimi et al. (2011): Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens +
T1: Day 1
T2: Day 2
T3: Day 3 +
Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? +
T0: Baseline (before radiojodtherapy)
T1: 6 months after radiojodtherapy +
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
T0: baseline
T1: after 3 weeks (day 22)
T2: after 5 weeks (day 36)
Follow-up: after 7 weeks (up to day 43) +
Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
T0: baseline
T1: after 3 weeks (day 22)
T2: after 5 weeks (day 36)
Follow-up: after 7 weeks (up to day 43) +
Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial +
Baseline + 7 weeks of radiotherapy
Median follow-Up in months: 12 (range: 2–24) +
Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial +
T0: Baseline
T1-T3: every worth week +
Freedland et al. (2020): A Randomized Controlled Trial of a 6-month low carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2) +
T0: baseline
T1: after 3 months
T2: after 6 months +
G
Ghoreishi et al. (2007): Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation +
"The grade of mucositis was recorded daily from day 7 (the first day of conditioning regimen and the beginning of supplementation with vitamin E) until the 28th day after BMT (a total of 35 days), in a chart designed for each patient." +
Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial +
Described unclear +
Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer +
T0: before radiotherapy
Once a week during radiotherapy
After radiotherapy +
Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial +
T0: baseline
T1: one day before chemotherapy
T2: day 8 of each cycle
T3: between 30-42 days after end of intervention +
Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers +
T0: Baseline
T1: weekly for 8 weeks during radiation
Follow up 1: 6-8 weeks after end of radiation
Follow-up 2: 2-3 month after end of radiation
Follow-up 3: 5-6 month after end of radiation +
H
Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial +
T0: before operation
T1-T3: on day 1-3 after operation
T4: on day 5 after operation +
Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) +
Weekly during radiotherapy;
At 1, 2, 3, and 6 months after radiotherapy completion +
Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue +
T0: baseline = day 1 of radiation treatment
T1: weekly throughout radiation treatment
Follow-up: 2 weeks after treatment +
Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer +
T0: week -1 radiotherapy
T1: 3 months after radiotherapy (20 weeks after T0) +